Product image of Васталома (Fulvestrant) supplied by GNH India

Васталома

Active Ingredient:
Fulvestrant
Origin:
EU

Васталома (Fulvestrant)

Васталома (fulvestrant) is an intramuscular injection used for hormone receptor-positive breast cancer treatment. This estrogen receptor antagonist helps manage advanced or metastatic conditions. Fulvestrant works by blocking estrogen receptors, slowing tumor growth. Suitable for postmenopausal women with HR-positive, HER2-negative breast cancer.

Manufacturer / TM Owner

Zentiva, K.S.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Indications & Clinical Uses

  • Fulvestrant is prescribed for treating hormone receptor-positive (HR+) metastatic breast cancer in postmenopausal women. It is used when cancer progresses after anti-estrogen therapy, such as tamoxifen or aromatase inhibitors. Fulvestrant is also indicated for postmenopausal women with HR+ advanced breast cancer not previously treated with endocrine therapy. The medication targets estrogen receptors to slow cancer cell growth.

Side Effects

  • Fulvestrant may cause injection site reactions, including pain, redness, or swelling. Some patients experience nausea, fatigue, or hot flashes as common effects. Headaches and bone pain are also reported by users. These effects vary in intensity and typically diminish over time. Regular monitoring is recommended during treatment.

Precautions & Warnings

  • Fulvestrant should be handled with care to avoid accidental needle sticks. Patients with bleeding disorders or low platelet counts require close supervision. Inform your healthcare provider about all medications and medical conditions before starting fulvestrant. Avoid driving or operating machinery if you experience dizziness or fatigue after the injection.

Avoid Interactions

  • Fulvestrant may interact with medications that affect liver enzymes, such as CYP3A4 inhibitors or inducers. Blood thinners like warfarin should be monitored closely due to potential interaction risks. Hormonal therapies or supplements containing estrogen may reduce fulvestrant’s effectiveness. Always disclose all current medications to your healthcare provider.

Frequently Asked Questions

Fulvestrant is used to treat hormone receptor-positive metastatic breast cancer in postmenopausal women.

Fulvestrant is given as an intramuscular injection, typically in the buttock area.

Common side effects include injection site reactions, nausea, fatigue, and hot flashes.

Consult your healthcare provider before combining fulvestrant with other drugs, as interactions may occur.

Fulvestrant is not recommended for use during pregnancy due to potential risks to the fetus.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Fulvestrant

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT